Skip to content

Homeopathic medicines for knee pain

Efficacy of individualized homoeopathic medicines selected using polarity analysis in reducing the pain of knee osteoarthritis in adults: A double-blind, randomized, placebo-controlled trial - Nil

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065097
Enrollment
90
Registered
2024-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies plus concomitant care: Intervention is planned as administering the indicated homoeopathic remedy in centesimal potencies,
dosage and repetition will depend upon the individual requirements of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking, or brushing teeth wit

Sponsors

D. N. De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 50-70 years 2.Participants of either sex or transgender. 3.Diagnosed knee OA (ICD 11- FA01) as per American College of Rheumatology (ACR) clinical/radiographic classification criteria a. Knee pain b. At least 1 of 3: age more than 50 yrs., stiffness less than 30 min, and crepitus on knee motion. c. Osteophytes on knee x-ray 4. Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of OA, provided the medications are stopped completely at least 2 weeks prior study entry. 5. At least 5 polar symptoms and 10 indicated remedies under a rubric. 6. Participants having prior experience or knowledge of the treatment. e.g.- primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.

Exclusion criteria

Exclusion criteria: 1. Not providing with written informed consent of participation. 2. Severe degeneration of knee joint with marked joint narrowing, varus, or valgus deformity of knee (more than 12°), evidenced by imaging or other evidences and requiring surgical intervention. 3. Non-ambulant patients. 4. Self-reported joint disorders other than osteoarthritis (e.g., inflammatory joint disease, specific arthropathy, hyperuricaemia and/or gout, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs) 5. Intra-articular injections within 2 weeks before study entry. 6. Transplanted knees. 7. Recent significant knee surgery within last 6 months. 8. Benign tumours and malignant tumours. 9. Patient suffering from active or chronic, systemic or local infection or disease. 10. Patients who are too sick for consultation. 11. Unwilling to take part and not giving consent to join the study 12. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life. 13. Pregnancy, puerperal women and lactating mother. 14. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool). 15. Self-reported immune-compromised state, AIDS, hepatitis etc. 16. Undergoing homoeopathic treatment for any chronic disease within last 6 months. 17. Simultaneous participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
Modified Pain Detection (mPDQ) questionnaireTimepoint: Every month up to 3 months

Secondary

MeasureTime frame
Knee Injury and Osteoarthritis Outcome Score (KOOS) Timepoint: Every month up to 3 months;Measure Yourself Medical Outcome Profile (MYMOP-2) Timepoint: Every month up to 3 months;Time to resolution of pain of kneeTimepoint: Every week up to 3 months

Countries

India

Contacts

Public ContactDr Subhranil Saha

D. N. De Homoeopathic Medical College and Hospital

drsubhranilsaha@hotmail.com8777382128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026